BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform

Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-leading institution in genomics research and innovation

Read more at globenewswire.com